Research Advances in the Prevention and Treatment of Perioperative Anemia in Patients Undergoing Coronary Artery Bypass Grafting

doi:10.3969/j.issn.1671-2587.2023.04.025

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2023, Vol. 25 ›› Issue (4): 555-558.DOI: 10.3969/j.issn.1671-2587.2023.04.025

Previous Articles Next Articles

Research Advances in the Prevention and Treatment of Perioperative Anemia in Patients Undergoing Coronary Artery Bypass Grafting

GAO Yuan, GAO Xurong, GAO Jie, et al

Department of Blood Transfusion,Fuwai Hospital Chinese Academy of Medical Sciences,Beijing 100037

Received:2023-05-26 Online:2023-08-20 Published:2023-09-18

Abstract

Abstract: Anemia leads to increased perioperative blood transfusion rate and blood transfusion volume, prolonged hospital stay in coronary artery bypass grafting patients, and is also an independent risk factor for postoperative complications and mortality.Patient blood management is a patient-centered, systematic, evidence-based approach to improve patient outcomes through the diagnosis and treatment of perioperative anemia and the protection of autologous blood.This paper reviews the research progress in the prevention and treatment of perioperative anemia in patients with coronary artery bypass grafting, which hopely improves the treatment plan and clinical outcome of patients with anemia after coronary artery bypass grafting.

Key words: Anemia, Coronary artery bypass grafting, Patient blood management

CLC Number:

R457

GAO Yuan, GAO Xurong, GAO Jie, et al. Research Advances in the Prevention and Treatment of Perioperative Anemia in Patients Undergoing Coronary Artery Bypass Grafting[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(4): 555-558.

References

[1] LAPAR D J,HAWKINS R B,MCMURRY T L,et al.Preoperative anemia versus blood transfusion:which is the culprit for worse outcomes in cardiac surgery?[J].J Thorac Cardiovasc Surg,2018,156(1):66-74.e2.
[2] 北京医学会输血医学分会,北京医师协会输血专业专家委员会.患者血液管理——术前贫血诊疗专家共识[J].中华医学杂志,2018,98(30):2386-2392.
[3] SHANDER A,HARDY J F,OZAWA S,et al.A global definition of patient blood management[J].Anesth Analg,2022,135(3):476-488.
[4] KIM C J,CONNELL H,MCGEORGE A D,et al.Prevalen ce of preoperative anaemia in patients having first-time cardiac surgery and its impact on clinical outcome.A retrospective observational study[J].Perfusion,2015,30(4):277-283.
[5] CARRASCAL Y,MAROTO L,REY J,et al.Impact of preoperative anemia on cardiac surgery in octogenarians[J].Interact CardioVasc Thorac Surg,2010,10(2):249-255.
[6] MICELI A,ROMEO F,GLAUBER M,et al.Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery[J].J Cardiothorac Surg,2014,9:137.
[7] MAZLAN A,AYOB Y,HUSSEIN A,et al.Factors influencing transfusion requirement in patients undergoing first-time,elective coronary artery bypass graft surgery[J].Asian J Transfus Sci,2017,11(2):95.
[8] HUNG M,BESSER M,SHARPLES L D,et al.The prevalence and association with transfusion,intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients[J].Anaesthesia,2011,66(9):812-818.
[9] CAMASCHELLA C.Iron deficiency:new insights into diagnosis and treatment[J].Hematology,2015,2015(1):8-13.
[10] 王文婷,刘晋萍.促红细胞生成素在心血管手术中应用的研究进展[J].临床麻醉学杂志,2023,39(1):89-92.
[11] CHO B C,SERINI J,ZORRILLA-VACA A,et al.Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients:results from a systematic review and meta-analysis[J].Anesth Analg,2019,128(5):981-992.
[12] TANAKA A,OTA T,URIEL N,et al.Cardiovascular surgery in Jehovah’s Witness patients:the role of preoperative optimization[J].J Thorac Cardiovasc Surg,2015,150(4):976-983.e1-3.
[13] D'AMBRA M N.Commentary:we need to know more about erythropoietin[J].JTCVS Tech,2020,4:158-159.
[14] CHO B C,SERINI J,ZORRILLA-VACA A,et al.Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients:results from a systematic review and meta-analysis[J].Anesth Analg,2019,128(5):981-992.
[15] DUCE L,COOTER M,MCCARTNEY S,et al.Outcomes in patients undergoing cardiac surgery who decline transfusion and received erythropoietin compared to patients who did not:a matched cohort study[J].Anesth \& Analg,2017,127:490-495.
[16] 张宗久,胡豫,Axel Hofmann,等.促进实施患者血液管理的专家倡议[J].中国卫生质量管理,2022,29(9):81-86.
[17] 中华人民共和国国家卫生健康委员会.围手术期患者血液管理指南(WS/T 796-2022)[EB/OL].(2022-01-21)[2022-05-07].http:// www.nhc.gov.cn/wjw/s9493/202202 /5e3bc1a664094da692bcb3e2e85efd34.shtml.
[18] 程珍珍,姚媛媛,严敏.成人心脏手术患者围术期贫血管理研究进展[J].中国输血杂志,2022,35(5):582-586.
[19] HIRATA Y.Cardiopulmonary bypass for pediatric cardiac surgery[J].Gen Thorac Cardiovasc Surg,2018,66(2):65-70.
[20] GROCOTT H P,FARAONI D.Avoidance of hyperoxemia during cardiopulmonary bypass:why does pathophysiology not always translate into clinical outcome?[J].Anesthesiology,2018,128(2):419.
[21] MAZZONE A L,BAKER R A,MCNICHOLAS K,et al.Circulating and urinary miR-210 and miR-16 increase during cardiac surgery using cardiopulmonary bypass-A pilot study[J].J Extra Corpor Technol,2018,50(1):19-29.
[22] 胡强,袁媛,于坤,等.氨甲环酸对于不同体外循环预充液凝血功能的影响[J].中国分子心脏病学杂志,2021,21(4):4091-4095.
[23] BOETTCHER W,REDLIN M,DEHMEL F,et al.Asanguineous priming of miniaturized paediatric cardiopulmonary bypass circuits for congenital heart surgery:independent predictors associated with transfusion requirements and effects on postoperative morbidity[J].Eur J Cardiothorac Surg,2018,53(5):1075-1081.
[24] 李倩,吕红,刘岳,等.心血管手术围术期抗纤溶治疗的有效性及安全性[J].中国临床药理学与治疗学,2021,26(7):830-835.
[25] COUTURE P,LEBON J S,LALIBERTÉ É,et al.Low-dose versus high-dose tranexamic acid reduces the risk of nonischemic seizures after cardiac surgery with cardiopulmonary bypass[J].J Cardiothorac Vasc Anesth,2017,31(5):1611-1617.
[26] PABINGER I,FRIES D,SCHÖCHL H,et al.Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis[J].Wien Klin Wochenschr,2017,129(9/10):303-316.
[27] RUNYON M S.Topical tranexamic acid for epistaxis in patients on antiplatelet drugs:a new use for an old drug[J].Acad Emerg Med,2018,25(3):360-361.
[28] SHI J,ZHOU C H,PAN W,et al.Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery:the OPTIMAL randomized clinical trial[J].JAMA,2022,328(4):336-347.
[29] 田丽娟,纪宏文,康文英,等.快速血栓弹力图对冠状动脉旁路移植术后严重出血危险因素的评估研究[J].北京医学,2020,42(10):992-996.
[30] 刘刚,李勇男,刁晓林,等.新型改良低预充体外循环系统的临床应用[J].中国体外循环杂志,2020,18(5):295-300.
[31] 高思哲,周纯,闫姝洁,等.新型改良低预充体外循环系统在成人心脏外科手术中有效性的随机对照试验方案[J].中国体外循环杂志,2022,20(5):272-275.
[32] 刘燕,王中,张达雄,等.血液回收技术在心外科手术中的应用[J].中国输血杂志,2003,16(1):14-15.
[33] 谢鹏禄,董书强,张兆喻,等.自体血液回收在心血管手术中及术后的应用[J].临床军医杂志,2014,42(5):544-545.
[34] SHOU B L,ARAVIND P,ONG C S,et al.Early reexploration for bleeding is associated with improved outcome in cardiac surgery[J].Ann Thorac Surg,2023,115(1):232-239.
[35] 申聪玉,钟泰迪.体外循环下心脏手术术后再次开胸止血原因分析及处理[J].浙江医学,2018,40(10):1113-1114.
[36] 中华人民共和国国家卫生健康委员会.儿科输血指南(WS/T 795-2022)[EB/OL].(2022-01-21)[2022-06-01].http://www.nhc.gov.cn/fzs/s7852d/202202/1484f47dcf824ee8bae3ad7b6809e603/files/d1cfad6849c945b591556494b3de7d2d.
[37] CARSON J L,CARLESS P A,HEBERT P C.Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion[J].Cochrane Database Syst Rev,2012,4(4):CD002042.
[38] ROUBINIAN N H,ESCOBAR G J,LIU V,et al.Trends in red blood cell transfusion and 30-day mortality among hospitalized patients[J].Transfusion,2014,54(10 Pt 2):2678-2686.
[39] MAZER C D,WHITLOCK R P,FERGUSSON D A,et al.Restrictive or liberal red-cell transfusion for cardiac surgery[J].N Engl J Med,2017,377(22):2133-2144.
[40] MAZER C D,WHITLOCK R P,FERGUSSON D A,et al.Six-month outcomes after restrictive or liberal transfusion for cardiac surgery[J].N Engl J Med,2018,379(13):1224-1233.
[41] 高洁,纪宏文.成人心血管外科围术期患者血液管理研究进展[J].北京医学,2022,44(8):746-749.

Research Advances in the Prevention and Treatment of Perioperative Anemia in Patients Undergoing Coronary Artery Bypass Grafting

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	HU Heng-ya, ZHOU Xiao-yu. The Effect of Preoperative Anemia on Perioperative Transfusion and Postoperative Outcomes in Children with Congenital Heart Disease [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(6): 721-724.
[2]	WEI Chao, XU Jun-Yue, XI Chao-Yun, et al. Retrospective Analysis on Characteristics and Influencing Factors of Blood Transfusion in Elderly Orthopedic Patients [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(6): 736-742.
[3]	SONG Qian, MA Yi-ran. Therapeutic Efficacy of Red Blood Cell Transfusions in Patients with Positive Crossmatching Test Caused by Autoantibodies [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(5): 588-590.
[4]	PAN Xue, SONG Ying-Wei, LIN Jie, et al. Effects of Preoperative Anemia on Perioperative Blood Transfusion and Clinical Outcomes in Patients Undergoing Orthopedic Surgery [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 409-415.
[5]	ZHOU Lin, CI Xuan, SHAO Xiao-bao, et al. Correlation between Perioperative Blood Transfusion and Postoperative Inflammatory Complications in Patients with Colorectal Cancer [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(4): 416-421.
[6]	LI Jin-qi, ZANG yan, LI Jin-ying, et al. Blood Transfusion Therapy in Children with Hereditary Refractory Hemolytic Anemia：A Retrospective Analysis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 325-327.
[7]	LI Ju, ZHU Wen-juan. Establishment of a Nomogram Model for Individualized Prediction of the Risk of Anemia in Patients with Malignant Lymphoma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 369-373.
[8]	ZHAO Xing-dan, FU Xiao-ling, WENG Ai-han. Anemia-Related Factors in Very Low Birth Weight Infants and Establishment of an Assessment Model [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 202-206.
[9]	ZHAO Feng-yong, ZHANG Yu-yu, WANG Zhong-ying, et al. Application of Flow Cytometry to the Detection of Blood Group Isoantibodies under the Cover of Autoantibodies in Autoimmune Hemolytic Anemia Patients [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(1): 6-10.
[10]	LIU Cheng-yi, CHEN Yuan, LI Huan, et al. Analysis on Clinical Application of Fetal Intrauterine Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(1): 38-42.
[11]	CHEN Feng, ZHENG Yang-yang. Characteristics of Antibiotic-Induced Red Blood Cell Antibodies in 358 Patients with Anemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 327-332.
[12]	DING Li, CHENG Li. Application of Enhanced Safety Nursing Based on Evidence-based Concept in Patients with Severe Renal Anemia during Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 329-333.
[13]	GUO Hui. The Value of HbA2 and Indexes of Red Blood Cells in Differential Diagnosis of Iron Deficiency Anemia and α-Thalassemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(5): 499-501.
[14]	CAI Xiao-yu, LIN Jie, WANG Chao, et al. Construction of Multi-center Clinical Preoperative Anemia Database [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(4): 337-340.
[15]	YE Zhen, WANG Shu-ping, CHEN Hui-fen, et al. Analysis of Pregnant Women with Positive Irregular Antibodies Treated with Intrauterine Blood Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(4): 355-358.